The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Smallholders unable to afford essential farm inputs, expert says
- Farmers say high costs drive up catfish prices
- NEWSAN calls for urgent repairs to sewage systems
- Rising feed costs push farmers out of business
- Naira slips to ₦1,379.99/$ as interbank FX turnover tops $500m
- FAAC shares ₦2.44trn October revenue as statutory, VAT receipts decline
- State trains veterinarians to expand rural services
- UniCal Alumni turn to agribusiness to tackle graduate unemployment
